ResearcherSecond Military Medical UniversityActive in the last 2 years
Luguang Chen
Matched on ORCID iD 0000-0002-3742-9439; OpenAlex author ID A5068257440. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2016: 1 paper · 2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 4
- Values of apparent diffusion coefficient in pancreatic cancer patients receiving neoadjuvant therapy. Co-author DOI 10.1186/s12885-024-12934-y↗
- Optimized ROI size on ADC measurements of normal pancreas, pancreatic cancer and mass-forming chronic pancreatitis. Co-author DOI 10.18632/oncotarget.18457↗
- Aberrant expression of STYK1 and E-cadherin confer a poor prognosis for pancreatic cancer patients. Co-author DOI 10.18632/oncotarget.22794↗
- In vitro and in vivo targeting imaging of pancreatic cancer using a Fe3O4@SiO2 nanoprobe modified with anti-mesothelin antibody. Co-author DOI 10.2147/ijn.s104501↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chao Ma · 3 shared papers, 2017–2024 · strength 0.34
- Paper Values of apparent diffusion coefficient in pancreatic cancer patients receiving neoadjuvant therapy. DOI 10.1186/s12885-024-12934-y↗
- Paper Aberrant expression of STYK1 and E-cadherin confer a poor prognosis for pancreatic cancer patients. DOI 10.18632/oncotarget.22794↗
- Paper Optimized ROI size on ADC measurements of normal pancreas, pancreatic cancer and mass-forming chronic pancreatitis. DOI 10.18632/oncotarget.18457↗
- Chengwei Shao · 3 shared papers, 2016–2024 · strength 0.34
- Paper Values of apparent diffusion coefficient in pancreatic cancer patients receiving neoadjuvant therapy. DOI 10.1186/s12885-024-12934-y↗
- Paper Aberrant expression of STYK1 and E-cadherin confer a poor prognosis for pancreatic cancer patients. DOI 10.18632/oncotarget.22794↗
- Paper In vitro and in vivo targeting imaging of pancreatic cancer using a Fe3O4@SiO2 nanoprobe modified with anti-mesothelin … DOI 10.2147/ijn.s104501↗
- Jianping Lu · 2 shared papers, 2017–2024 · strength 0.28
- Yun Bian · 2 shared papers, 2017–2024 · strength 0.28
- Panpan Yang · 2 shared papers, 2017–2024 · strength 0.27
- Yufei Chen · 1 shared paper, 2024 · strength 0.21
- Jianping Lu · 1 shared paper, 2017 · strength 0.06
- Qiang Hao · 1 shared paper, 2017 · strength 0.06
- Li Wang · 1 shared paper, 2017 · strength 0.06
- Fang Liu · 1 shared paper, 2016 · strength 0.06
- Bingdi Chen · 1 shared paper, 2016 · strength 0.06
- Zheng Cui · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.